Molecular basis of individual susceptibility to xenobiotics;Bases moleculaires de la susceptibilite aux xenobiotiques: Aspects metaboliques

Medecine/Sciences

Volumn 16, Issue 10, 2000, Pages 1051-1056

  Beaune, P H ^a   Loriot, M A ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALDEHYDE DEHYDROGENASE; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; BENZO[A]PYRENE; CARBAMAZEPINE; CIGARETTE SMOKE; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; MERCAPTOPURINE; STEROID; THIOPURINE METHYLTRANSFERASE; XENOBIOTIC AGENT;

ARTICLE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; HEREDITY; HUMAN; HYDROPHILICITY; LUNG CANCER; NONHUMAN; PATHOPHYSIOLOGY; SMOKING; XENOBIOTIC METABOLISM;

EID: 0033783737     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1524     Document Type: Article

References (23)

1. Les cytochromes P450 humains: Applications en toxicologie
2. Bile acid and xenobiotic transporters in liver
3. Export pumps for glutathione S-conjugates
4. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility
5. Genetic control of isoniazid metabolism in man
6. Polymorphic hydroxylation of debrisoquine in man
7. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
8. Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment
9. Genetic epidemiology of environmental toxicity and cancer susceptibility: Human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues
10. Duplication, multiduplication, and amplification of genes encoding drug-metabolizing enzymes: Evolutionary, toxicological, and clinical pharmacological aspects
11. Induction of human drug metabolizing enzymes: Mechanisms and-implication
12. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis
13. Induction of cytochrome P4501A1
14. Les arylamine N-acetyltransferases: Du polymorphisme genetique a la susceptibilite aux xenobiotiques
15. Pharmacogenetics as a molecular basis for individualized drug therapy: The thiopurine S-methyltransferase paradigm
16. Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance
17. Pharmacogenomics: Translating functional genomics into rational therapeutics
18. Genetic polymorphism of drug-metabolizing enzymes and lung cancer suceptibility
19. Association between lung cancer and microsomal epoxide hydrolase
20. Tobacco smoke carcinogens and lung cancer
21. Preferential formation of Benzo (a)pyrene adducts at lung cancer mutational hotspots in p53
22. Environment and cancer: Who are susceptible?